Redsense Cares about Your Safety
Our vision is to save lives by detecting blood loss, using a patented core technology that utilizes fiber optics.
The Redsense blood loss detection solution is specifically designed to detect blood leakage through core technology utilizing fiber optics. Detected blood triggers a visual and audible alarm; thus giving patients, nurses and caregivers some extra peace of mind.
Redsense Medical AB announces today that an evaluation programme is launching in the Netherlands to test a new version of the Redsense Alarm, with additional functionality that has been developed in response to clinical experiences – a direct connection for the unit into the nurse call system of the clinic. The evaluation will comprise 100-150 […]
As of today, the Annual Report for Redsense Medical AB (publ.) For the 2019 financial year is available for download. Rapport på Svenska Report in English A printed version can be ordered from: Redsense Medical AB Gyllenhammars väg 26 302 92 Halmstad
Redsense Medical AB (publ) håller årsstämma måndagen den 22 juni 2020 klockan 16.30 på Halmstad Lasarett, Sal: Ankaret, Ingång 19 A (gamla huvudentrén), Lasarettsvägen, Halmstad. Inregistrering sker från klockan 16.15. Före bolagsstämman visas bolagets produkter upp. RÄTT ATT DELTA OCH ANMÄLAN TILL BOLAGET Den som önskar delta i stämman ska dels vara införd […]
CEO Patrik Byhmer visited Biostock Studio and comments on Q1 2020 report in interview. “Redsense Medical has developed an alarm system that detects and warns of life-threatening blood leakage in connection with dialysis treatment. This is after a sales increase of 154 percent and the company’s first listed net profit as CEO Patrik Byhmer visits […]